Abstract: The present invention relates to an antibody against delta-like 1 homolog (Drosophila) (DLK1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector comprising the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, an antibody drug conjugate (ADC) comprising the same, a pharmaceutical composition for treating cancer, a composition for diagnosing cancer, and a chimeric antigen receptor (CAR) and a T-cell engager comprising the same.

Abstract: Disclosed are an antibody to human programmed cell death 1 (PD-1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, an isolated cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, and a composition for preventing or treating cancer containing the same. The novel antibody binding to PD-1 or an antigen-binding fragment thereof can bind to PD-1 and inhibit the activity of PD-1, thus being useful for the development of immunotherapeutic agents for various diseases associated with PD-1.

Abstract: A small-sized motor apparatus for a vehicle, includes: a frame; a drive shaft mounted to the frame, a driven shaft to rotate dependently on the drive shaft, the driven shaft including a second worm gear; a cover coupled to the frame; a plate-shaped washer member; and a gap spring member preventing an axial movement of the driven shaft, the gap spring member being assembled in a radial direction of the driven shaft and installed such that one side of the gap spring member is contact-supported by the plate-shaped washer member and the other side of the gap spring member is supported by the frame, wherein the frame includes a slide groove that accommodates both ends of the gap spring member and the plate-shaped washer member and restricts the gap spring member from moving in an axial direction of the driven shaft.

Abstract: The present invention relates to a pharmaceutical composition for preventing greying of hair, and preventing or treating poliosis or vitiligo. The pharmaceutical composition of the present invention increases intracellular melanin content, accelerates or increases melanoblast migration, pre-emptively prevents gray hair formation, and accelerates dark hair formation, and thus may be beneficially used in the prevention or alleviation of greying of hair, and in the prevention, alleviation or treatment of poliosis or vitiligo.

Abstract: The present invention relates to an antibody against delta-like 1 homolog (Drosophila) (DLK1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector comprising the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, an antibody drug conjugate (ADC) comprising the same, a pharmaceutical composition for treating cancer, a composition for diagnosing cancer, and a chimeric antigen receptor (CAR) and a T-cell engager comprising the same.

Abstract: A semiconductor device and a method of fabricating a semiconductor device, the device including a fin-type pattern extending in a first direction; a gate electrode extending in a second direction over the fin-type pattern, the second direction being different from the first direction; spacers on sidewalls of the gate electrode; a capping structure on the gate electrode and the spacers, the capping structure including a first capping pattern and a second capping pattern, the second capping pattern being on the first capping pattern; and an interlayer insulating film surrounding sidewalls of each of the spacers and sidewalls of the capping structure, the interlayer insulating film being in contact with the first capping pattern.

Abstract: A method for monitoring a downlink control channel, the method performed by a user equipment (UE) configured with multiple carriers includes determining whether to monitor the downlink control channel within either one UE-specific search space or a plurality of UE-specific search spaces, and monitoring the downlink control channel within the plurality of UE-specific search spaces if carrier index is configured, wherein each of the plurality of the UE-specific search spaces is determined based on the carrier index.

Abstract: Disclosed are an antibody to human programmed cell death-ligand 1 (PD-L1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, and a composition for preventing or treating cancer or infectious diseases containing the same.

Abstract: A semiconductor device includes a first interlayer insulating film; a conductive connection structure provided in the first interlayer insulating film; a second interlayer insulating film provided on the first interlayer insulating film; a wiring structure provided in the second interlayer insulating film and connected to the conductive connection structure; and an insertion liner interposed between an upper surface of the conductive connection structure and the wiring structure, the insertion liner including carbon.

Abstract: A separator for a rechargeable lithium battery includes a substrate; and a coating layer positioned on at least one side of the substrate, wherein a thickness ratio of the coating layer relative to the total thickness of the substrate and the coating layer ranges from about 5% to about 50%, and a loading level of the coating layer ranges from about 1.4 g/m2 to about 9.8 g/m2, and a rechargeable lithium battery including the same is provided.

Abstract: A method for monitoring a downlink control channel, is performed by a user equipment (UE) configured with multiple carriers and includes receiving information on carrier index, determining a plurality of UE-specific search spaces for monitoring the downlink control channel, and monitoring the downlink control channel within the plurality of UE-specific search spaces, wherein location of each of the plurality of the UE-specific search spaces is determined based on the carrier index.

Abstract: A small-sized motor apparatus for a vehicle, includes: a frame; a drive shaft mounted to the frame, a driven shaft to rotate dependently on the drive shaft, the driven shaft including a second worm gear; a cover coupled to the frame; a plate-shaped washer member; and a gap spring member preventing an axial movement of the driven shaft, the gap spring member being assembled in a radial direction of the driven shaft and installed such that one side of the gap spring member is contact-supported by the plate-shaped washer member and the other side of the gap spring member is supported by the frame, wherein the frame includes a slide groove that accommodates both ends of the gap spring member and the plate-shaped washer member and restricts the gap spring member from moving in an axial direction of the driven shaft.

Abstract: The present invention provides buckling inducing-type vehicle crash boxes. The buckling inducing-type vehicle crash boxes are arranged at both ends of a back beam and comprise: a box body part; and a reinforcing part, which is formed in a lattice shape, is formed to integrally protrude from the outer surface of the box body part, induce buckling along the longitudinal direction of the box body part by an external impact, and absorb energy generated by to the impact.

Abstract: Disclosed are an antibody to human programmed cell death-ligand 1 (PD-L1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, and a composition for preventing or treating cancer or infectious diseases containing the same.

Abstract: The present invention relates to compositions and methods for treating fatty liver, steatohepatitis, or liver cirrhosis as well as insulin resistance and aging by administration of a DLK1-Fc fusion protein constructed by conjugation of an extracellular domain of DLK1 or a fragment thereof with a human antibody Fc region. Also provided are health functional foods containing a DLK1-Fc fusion protein constructed by conjugation of an extracellular domain of DLK1 (delta-like 1 homolog) or a fragment thereof with a human antibody Fc region as an active ingredient.

Abstract: Semiconductor devices and methods for fabricating the same are provided. A semiconductor device may include a substrate including first and second regions, a first interface film disposed on the substrate in the first region, a second interface film disposed on the substrate in the second region, a dielectric film disposed on the first and second interface films, a first metal film disposed on the dielectric film in the first region, and a second metal film disposed on the dielectric film in the second region. The first and second interface films may comprise an oxide of the substrate, the first and second metal films may comprise different materials, and the first and second interface films may have different thicknesses. Channels may be provided in the first and second regions, and the channels may be fin-shaped or wire-shaped. The metal films may have different oxygen content.

Abstract: Disclosed are an antibody to human programmed cell death 1 (PD-1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, an isolated cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, and a composition for preventing or treating cancer containing the same. The novel antibody binding to PD-1 or an antigen-binding fragment thereof can bind to PD-1 and inhibit the activity of PD-1, thus being useful for the development of immunotherapeutic agents for various diseases associated with PD-1.

Abstract: A method for monitoring a downlink control channel, is performed by a user equipment (UE) configured with multiple carriers and includes receiving information on carrier index, determining a plurality of UE-specific search spaces for monitoring the downlink control channel, and monitoring the downlink control channel within the plurality of UE-specific search spaces, wherein location of each of the plurality of the UE-specific search spaces is determined based on the carrier index.

Abstract: The present invention relates to an injection molding method using a fiber-reinforced composite material as an insert, and an injection molded product, and provides an injection molding method comprising: a step of preparing a fiber-reinforced composite material having a high-strength fiber, which is an insert material, impregnated in a resin; an insert formation step of manufacturing an insert by molding the fiber-reinforced composite material into a preliminary shape; and an injection molding step of manufacturing an injection product by arranging the insert in an injection mold and injecting a resin.

Abstract: Disclosed are a method and a device for transmitting uplink control information (UCI) by a terminal in a wireless communication system. The UCI transmission method comprises the steps of: generating an encoding information bit stream by performing channel coding for a UCI bit stream; generating complex modulation symbols by performing modulation for the generated encoding information bit stream; spreading the complex modulation symbols in block-wise on the basis of an orthogonal sequence; and transmitting the spread complex modulation symbols to a base station. The encoding information bit stream is generated by a channel coding for circularly repeating the UCI bit stream.